These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35260123)

  • 21. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
    Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
    Elife; 2021 Jun; 10():. PubMed ID: 34165077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow fever: a decade of reemergence.
    Robertson SE; Hull BP; Tomori O; Bele O; LeDuc JW; Esteves K
    JAMA; 1996 Oct; 276(14):1157-62. PubMed ID: 8827969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1987 yellow fever epidemics in Oyo State, Nigeria: a survey for yellow fever virus haemagglutination inhibiting antibody in residents of two communities before and after the epidemics.
    Olaleye OD; Omilabu SA; Faseru O; Fagbami AH
    Virologie; 1988; 39(4):261-6. PubMed ID: 2851207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser LG
    Curr Opin Infect Dis; 2019 Oct; 32(5):390-393. PubMed ID: 31335440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of yellow fever in central and southwestern Uganda, February-may 2016.
    Kwagonza L; Masiira B; Kyobe-Bosa H; Kadobera D; Atuheire EB; Lubwama B; Kagirita A; Katushabe E; Kayiwa JT; Lutwama JJ; Ojwang JC; Makumbi I; Ario AR; Borchert J; Zhu BP
    BMC Infect Dis; 2018 Nov; 18(1):548. PubMed ID: 30390621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis.
    Shearer FM; Moyes CL; Pigott DM; Brady OJ; Marinho F; Deshpande A; Longbottom J; Browne AJ; Kraemer MUG; O'Reilly KM; Hombach J; Yactayo S; de Araújo VEM; da Nóbrega AA; Mosser JF; Stanaway JD; Lim SS; Hay SI; Golding N; Reiner RC
    Lancet Infect Dis; 2017 Nov; 17(11):1209-1217. PubMed ID: 28822780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yellow Fever Disease: Pattern of Presentation of Patients in Federal Medical Centre, Asaba, Delta State, Nigeria.
    Aigbokhaode AQ; Orhue NL; Ojimba AO; Ugoeze FC; Origbo CE; Caleb D; Ezemenahi SI; Ekhator NP; Mkpuma U; Okereke JI; Osiatuma VA; Ezunu EO
    West Afr J Med; 2023 Apr; 40(4):428-434. PubMed ID: 37120797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Adrien N; Hyde TB; Gacic-Dobo M; Hombach J; Krishnaswamy A; Lambach P
    Vaccine; 2019 Jul; 37(32):4511-4517. PubMed ID: 31266670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow Fever: A Perennial Threat.
    Tuells J; Henao-Martínez AF; Franco-Paredes C
    Arch Med Res; 2022 Nov; 53(7):649-657. PubMed ID: 36404585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection and management of the yellow fever epidemic in the Ivory Coast, 2001].
    Akoua-Koffi C; Ekra KD; Kone AB; Dagnan NS; Akran V; Kouadio KL; Loukou YG; Odehouri K; Tagliante-Saracino J; Ehouman A
    Med Trop (Mars); 2002; 62(3):305-9. PubMed ID: 12244930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease.
    Silva NIO; Sacchetto L; de Rezende IM; Trindade GS; LaBeaud AD; de Thoisy B; Drumond BP
    Virol J; 2020 Jan; 17(1):9. PubMed ID: 31973727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
    Hamlet A; Jean K; Yactayo S; Benzler J; Cibrelus L; Ferguson N; Garske T
    Vaccine; 2019 Mar; 37(11):1384-1388. PubMed ID: 30770224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological aspects of the 1969 yellow fever epidemic in Nigeria.
    Carey DE; Kemp GE; Troup JM; White HA; Smith EA; Addy RF; Fom AL; Pifer J; Jones EM; Brès P; Shope RE
    Bull World Health Organ; 1972; 46(5):645-51. PubMed ID: 4538037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rom J Virol; 1993; 44(1-2):3-7. PubMed ID: 9702244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.
    Kleinert RDV; Montoya-Diaz E; Khera T; Welsch K; Tegtmeyer B; Hoehl S; Ciesek S; Brown RJP
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31627415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study.
    Kraemer MUG; Faria NR; Reiner RC; Golding N; Nikolay B; Stasse S; Johansson MA; Salje H; Faye O; Wint GRW; Niedrig M; Shearer FM; Hill SC; Thompson RN; Bisanzio D; Taveira N; Nax HH; Pradelski BSR; Nsoesie EO; Murphy NR; Bogoch II; Khan K; Brownstein JS; Tatem AJ; de Oliveira T; Smith DL; Sall AA; Pybus OG; Hay SI; Cauchemez S
    Lancet Infect Dis; 2017 Mar; 17(3):330-338. PubMed ID: 28017559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.